CVS Health raised its annual earnings outlook following strong performance at Aetna and the pharmacy segment in the second quarter, according to the company’s July 31 financial report.
CVS Health
The company reported total revenue of $98.9 billion in the second quarter, up from $91.2 billion posted during the same period last year.
Net income was $1 billion, down from $1.8 billion during the same period last year.
The company raised its 2025 outlook, projecting an adjusted earnings per share of $6.30 to $6.40 from $6.00 to $6.20.
Aetna
Aetna reported total revenues of $36.3 billion in the second quarter, an 11.6% increase year over year.
Adjusted operating income was $1.3 billion, a 39.4% increase year over year.
Aetna had a medical loss ratio of 89.9%, compared to 89.6% during the same quarter last year.
Medical membership as of June 30 was 26.7 million, reflecting a decrease of 358,000 members as the company winds down ACA operations.
At the end of the quarter, Aetna had 18.8 million commercial members, 4.2 million Medicare Advantage members, 1.2 million supplement members, 2.4 million Medicaid members and nearly 4.1 million Medicare Part D plan members.
Health services segment
The segment recorded total revenue of $46.4 billion in the second quarter, a 10.2% increase year over year.
Adjusted operating income was $1.6 billion, a 17.8% decrease year over year.
Total pharmacy claims processed was 469 million, a 0.5% decrease year over year.
Pharmacy and consumer wellness segment
The segment posted total revenue of $33.6 billion, up 12.5% year over year.
Adjusted operating income was $1.3 billion, a 7.6% increase year over year.
Prescriptions filled on a 30-day equivalent basis increased 4.2% year over year to 438.1 million.
